Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
News, developments and strategies related to eClinical, data management, data collection, ePRO, and more information technology used in the drug development chain. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
BBK Worldwide, the global leader in patient recruitment and retention for clinical research, announced today an expanded suite of products that streamlines retention efforts at the site level. Among these products are the Ready. Set. Go.SM Card (RSGSM Card), Ready. Set. Go.SM Ride (RSGSM Ride), and Ready. Set. Go.SM Minder (RSGSM Minder). These products are customized for today’s clinical research coordinator who is tasked with multiple responsibilities and demands. Through the efficiencies these products create, the clinical research coordinator is allowed to focus his or her efforts on other study-related priorities.
RSG Minder is a customized mobile platform that supports study participants and assists them in managing their study obligations. “Study participants have access to functionality that allows them to track upcoming study visits and schedule convenient reminders. In addition, content functionality allows BBK to send notifications to opted-in patients about upcoming visit reminders, post-visit follow-up, and general study information and updates,” comments Johnson.